These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22188379)

  • 1. Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.
    Green AR; King MV; Shortall SE; Fone KC
    Br J Pharmacol; 2012 Jul; 166(5):1523-36. PubMed ID: 22188379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of MDMA: Main effects and mechanisms.
    Costa G; Gołembiowska K
    Exp Neurol; 2022 Jan; 347():113894. PubMed ID: 34655576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
    Green AR; O'shea E; Colado MI
    Eur J Pharmacol; 2004 Oct; 500(1-3):3-13. PubMed ID: 15464016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
    Baumann MH; Wang X; Rothman RB
    Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.
    Monks TJ; Jones DC; Bai F; Lau SS
    Ther Drug Monit; 2004 Apr; 26(2):132-6. PubMed ID: 15228153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation.
    Parrott AC
    Br J Pharmacol; 2012 Jul; 166(5):1518-20; discussion 1521-2. PubMed ID: 22404300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
    Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
    Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
    Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.
    Mechan A; Yuan J; Hatzidimitriou G; Irvine RJ; McCann UD; Ricaurte GA
    Neuropsychopharmacology; 2006 Feb; 31(2):339-50. PubMed ID: 15999148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.
    Colado MI; O'Shea E; Green AR
    Psychopharmacology (Berl); 2004 May; 173(3-4):249-63. PubMed ID: 15083264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.
    Docherty JR; Green AR
    Br J Pharmacol; 2010 Jul; 160(5):1029-44. PubMed ID: 20590597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
    Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
    Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
    McCann UD; Eligulashvili V; Ricaurte GA
    Neuropsychobiology; 2000; 42(1):11-6. PubMed ID: 10867551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.
    Capela JP; Carmo H; Remião F; Bastos ML; Meisel A; Carvalho F
    Mol Neurobiol; 2009 Jun; 39(3):210-71. PubMed ID: 19373443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
    Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.
    Goni-Allo B; O Mathúna B; Segura M; Puerta E; Lasheras B; de la Torre R; Aguirre N
    Psychopharmacology (Berl); 2008 Apr; 197(2):263-78. PubMed ID: 18074122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
    Garg A; Kapoor S; Goel M; Chopra S; Chopra M; Kapoor A; McCann UD; Behera C
    Curr Drug Abuse Rev; 2015; 8(1):15-25. PubMed ID: 25731754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
    Johnson BN; Yamamoto BK
    J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.
    Shen EY; Ali SF; Meyer JS
    Neuropharmacology; 2011 Dec; 61(8):1183-92. PubMed ID: 21763331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.